Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy

NCT04360577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-06-12

No results posted yet for this study

Summary

In the investigator's pilot study(NCT 03753399), a trend of improvement of quality of life, as well as release of symptoms, in gastric patients in acupuncture groups was indicated. This study will evaluate the efficacy of acupuncture on QoL in gastric cancer patients undergoing postoperative adjuvant chemotherapy with more samples. Enrolled participates will randomly receive high-dose acupuncture, low-dose acupuncture or non-acupuncture during the first 3 cycles of adjuvant chemotherapy after resection.

Conditions

  • Stomach Neoplasms

Interventions

PROCEDURE

acupuncture

Acupuncture at back-shu points according to heat-pain threshold measurement at 24 well-points, combing with electro-acupuncture at Baihui(GV20), Yintang(GV29), Neiguan(PC6), Zusanli(ST36), and Gongsun(SP4).

Sponsors & Collaborators

  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Affiliated Hospital of Nanjing University of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Sixth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER
  • Southern Medical University, China

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University

    collaborator OTHER
  • Fifth Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • First People's Hospital of Foshan

    collaborator OTHER
  • Yuebei People's Hospital

    collaborator OTHER
  • Guangzhou University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Haibo Zhang, Prof. · Guangdong Provincial Hospital of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-27
Primary Completion
2023-03-23
Completion
2023-05-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04360577 on ClinicalTrials.gov